Pegfilgrastim

4 Drugs classified under this active ingredient

Colony Stimulating Factor, Immunostimulants. Pegfilgrastim 6 mg.
Pre-filled syringe 1 x 6 mg/0.6ml. One 6 mg dose for ea. chemother. cycle S.C. inject. at least 24 hours after cytotox. chemother.
Reduct. durat. neutropen., incidence of febrile neutropen. in pts. treated with cytotox. chemother. given in intervals of 14 days or more for malignancy (with the except. of chron. myeloid leukem. and myelodysplast. synds.). See lit.
C/I: Hyperens.

Colony Stimulating Factor. Pegfilgrastim 6 mg / 0.6 ml.
PREFILL SYRINGE (ready-to-use) 1 x 6
mg/0.06 ml. One 6 mg dose for ea.
chemother. cycle S.C. inject. approx.
24 hrs follow. cytotox. chemother.
Reduct. durat. neutropen., incidence of
febrile neutropen. in pts. treated with cytotox. chemother. for malignancy (with
the except. of chron. myeloid leukem. and
myelodysplast. synds.)
C/I: Hyperens.

granulocyte Colony Stimulating Factor (G-CSF). Pegfilgrastim 10 mg/ml.
Pre-filed syr1X 0.6 ml.
One 6 mg dose (a sgle. pre-filled syr.) for each chemother. cycle, given at least 24 hs. after cytotoxic chemother. See lit.
Reduct. in the durat. of neutropenia and incidence of febrile neutropenia in pts. treated with cytotoxic chemother., given at intervals of 14 days or more, for malignancy (with exception of chronic myeloid leukemia and myelodysplastic syndr).
C/I:Hypersens.

Colony Stimulating Factor. Pegfilgrastim 6 mg / 0.6 ml.
PREFILL. SYR.: 1 x 6 mg / 0.6 mL. One 6 mg for ea. chemother. cycle, S.C. inject. at least 24 hrs. after cytotox. chemother. See lit.
Reduct. durat. neutropen., incidence of febrile neutropen. in pts. treat. with cytotox. chemother.at interval. of 14 dys. or more, for malignan. (with the exception of chronic myeloid leukemia and myelodysplastic synd.).
C/I: Hypersens.